4th Immunogenicity is organized by SMi Group and would be held during Jun 12 - 13, 2017 at Holiday Inn London - Kensington Forum, London, England, United Kingdom. The target audience for this medical event are Immunologists.
Benefits of Attending:
• Guidance on UK, EU and USA regulations surrounding immunogenicity and best practice risk assessment
• Targeted focus on immunogenicity; identifying, addressing and removing challenges to industry
• Highlight best practise risk assessment and mitigation through high level case studies
• Explore novel and innovative approaches to reducing immunogenicity
• Spotlight on new technology; Humanising proteins and new biotherapeutic solutions
• Personalising treatments with next generation biologic drugs
Additional Details will be posted as soon as they are available.